JRI 

A morphologic and morphometric study of adult mouse testis following different doses of busulfan administration

Vol. 7, Issue 1, / April-June 2006
(pages 25-36)

Mohammad Amin Homafar Corresponding Author
- Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Jafar Soleimanirad
- Histology Department, Faculty of Medicine, Tabriz Medical Sciences University, Tabriz, Iran
Ahmad Ali Ghanbari
- Department of Anatomy, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Received: 4/1/2006 Accepted: 4/1/2006 - Publisher : Avicenna Research Institute

Related Articles
in Google Scholar
in PubMed

 

Other Format
pdfFull Text (En)
pdfFull Text (Fa)
pdfAbstract (En)
pdfAbstract (Fa)
pdfePUB (En)
pdfBibTeX
pdfRefMan
pdfEndNote
xmlPMC XML
online readerPMC Reader
online readerHBIs XML

 


Abstract

Introduction: Anti-cancer drugs have adverse effects on spermatogenesis. Therefore, informa-tion on their role for the prevention of germinal epithelium destruction is necessary. The aim of this study was morphologic and morphometric evaluations of testes, measurement of volume and volume density of testes parameters, measurement of tubular diameters, germ and somatic cell counts following administration of different doses of busulfan in adult mice. Materials & Methods: In the present study, 42 male NMRI mice aged 6-8 weeks were used. The animals were divided into 5 groups. Case groups received a single dose of busulfan by intraperitoneal injection as 5, 10, 20 and 40 mg/kg in the first, second, third and forth groups respectively. The control group received only the solvent for busulfan. All the animals were killed 35 days after treatment and their testes were dissected out and processed for light microscope studies. Then morphometric studies were performed on testicular parameters. The data were analyzed using ANOVA and Tukey test and p values less than 0.05 were considered significant. Results: Busulfan administration in 5, 10, 20 and 40 mg/kg doses significantly reduced most morphometric parameters in testes with a maximum effect in the 40 mg/kg group. Volumes of testes, tubules and germinal epithelia were decreased significantly in the experiment groups (p<0.05 ) however, the volume of interstitial tissue increased (p<0.05). tubular diameters and thickness of epithelia were also decreased in the experiment groups. number of germ cells was reduced, but number of sertoli cells was not affected. the number of leydig cells were not affected in 10 and 20 mg g busulfan treated groups, however in the 40 mg g treated group they were increased significantly (p<0.003). in 5 mg g treated group there were no significant differences in morphologic and morphometric studies. conclusion: busulfan could reduce testicular parameters and disrupt spermatogenesis through affecting both germ and somatic cells in a dose dependent manner. therefore, the side effects of busulfan on spermatogenesis should be considered during cancer therapies.< pan>


Keywords: Spermatogenesis, Busulfan, Morphometry, Mouse, Testis, Chemotherapy, Germ cells


To cite this article:


References

  1. Nudell D.M., Monoski M.M., Hipshultz L.I. Common medications and drugs: how they affect male fertility.Urol Clin North Am.2002;29(4):965-73.
  2. Howell S.J., Shalet S.M. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr.2005;(34):12-17.
  3. Puscheck E., Philip P.A., Jeyendran R.S., Male fertility preservation and cancer treatment. Cancer Treat Rev. 2004;30(2):173-180.
  4. Shetty G., Meistrich M.L. Hormonal approaches to pre-servation and restoration of male fertility after cancer treatment. J Natl cancer Inst Monogr.2005; (34):36-9.
  5. Silber S.J., Rodriguez- Rigau L.P. Quantitative analysis of testicle biopsy: determination of partial obstruction and prediction of sperm count after surgery for obstru-ction. Fertril Steril.1981;36:480.
  6. Anderson P.h.O., Knoben J.E., Troutman W.G. Hand-book of clinical data. Mc Graw Hill.10th Edition.2002; pp:136-140.
  7. Trevor A.J., Katzung B.G., Masters S.B. A long medical book Katzung & Trevors Pharmacology exa-mination and board review. Mc Graw Hill.2002;6th Edition.pp:206-8.
  8. Molenaar R., de Rooij D.G., Rommerts F.F, Reuvers P. J., van der Molen H.J. Specific destruction of Leydig cells in mature rats after in vivo administration of ethane dimethyl sulfonate. Biol Reprod.1985;33(5): 1213-22.
  9. Boujrad N., Hochereau-de Riviers M.T., Kamtchouing P., Perreau C., Carreau S. Evolution of somatic and germ cell populations after busulfan treatment in utero or neonatal cryptorchidism in the rat. Andrologia. 1995;27(4):223-8.
  10. Jansz G.F., Pomerantz D.K. The effect of prenatal treatment with busulfan on in vitro androgen produc-tion by testes from rats of various ages. Can J Physiol Pharmacol.1985;63(9):1155-8.
  11. Brinster R.L., Avarbock M.R. Germline transmission of donor haplotype following spermatogonial trans-plantation Proc Natl Acad Sci USA.1994;91:11303-7.
  12. Honaramooz A., Behboodi E., Hausler C.L., Blash S., Ayres S., et al. Depletion of endogenous germ cells in male pigs and goats in preparation for germ cell trans-plantation. J Androl. 2005;26(6):698-705.
  13. De Sanctis V., Galimberti M., Lucarelli G., Polchi P., Ruggiero L., Vullo C.Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child.1991;66(4):517-20.
  14. Grigg A.P., McLachlan R., Zaja J., Szer J. Reproduc-tive status in long-term bone marrow transplant survi-vors receiving busulfan-cyclophosphamide (120mg/kg) Bone Marrow Transplant.2000;26(10):1089-95.
  15. Afify Z., Shaw P.J., Clavano-Harding A., Cowell C.T. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/ cyclophosphamide. Bone Marrow Transplant.2000;25(10):1087-1092.
  16. Yang Z.W., Guo Y., Lin L., Wang X.H., Tong J.S., Zhang G.Y. Quantitative (stereological) study of in-complete spermatogenic suppression induced by testos-terone undecanoate injection in rats. Asian J Androl. 2004;6(4):291-7.
  17. Osinubi A.A., Noronha C.C., Okanlawon A.O., Mor-phometric and stereological assessment of the effects of long-term administration of quinine on the morpho-loyg of rat testis. West Afr J Med.2005;24(3):200-5.
  18. Vecino P., Uranga J.A., Arechaga J. Suppression of spermatogenesis for cell transplantation in adult mice. Protoplasma.2001;217(4):191-8.
  19. Aich S., Manna C.K. Histophysiological changes of the testicular tissue due to busulphan administration in the wild Indian house rat. Acta Biol Hung.2001;52 (1):105-16.
  20. Haddad S., Carvalho T.L., Anselmo-Franci J.A., Pete-nusci S.O., Favaretto A.L. Ultrasound stimulation of rat testes damaged by busulfan. Ultrasound Med Biol. 1997;23(9):1421-25.
  21. Bucci L.R., Meistrich M.L. Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. Mutat Res.1987;176(2):259-68.
  22. Mandarim-de-Lacerda C.A. Stereological tools in bio-medical research. An Acad Bras Cienc.2003;75(4):469 -86.
  23. Udagawa K., Ogawa T., Watanabe T., Yumura Y., Takeda M., Hosaka M. GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Int J Urol.2001;8(11): 615-22.
  24. Jiang F.X. Behavior of spermatogonia following reco-very from busulfan treatment in the rat. Anat Embryol (Berl).1998;198(1):53-61.
  25. Adler I.D. Comparison of the duration of spermato-genesis between male rodents and humans. Mutar Res. 1996;352(1-2):169-72.
  26. Cheng Yan C., Mruck D.D. Cell junction dynamic in the testis: sertoli-germ cell interaction and male contra-ceptive development. Physiol Rev.2002;82:825-874.
  27. Costa D.S., Paula T.A., Matta S.L. The intertubular compartment morphometry in capybaras (Hydrochoe-rus hydrochaeris) testis. Anim Reprod Sci.2006;91(1-2):173-9.
  28. Tae H.J., Jang B.G., Ahn D.C., Choi E.Y., Kang H.S., et al. Morphometric studies on the testis of Korean ring-necked pheasant (Phasianus colchicus karpowi) during the breeding and non-breeding seasons. Vet Res Commun.2005;29(7):629-43.
  29. Gunderson H.J., Bagger P., Bendtsen T.F., Evans S. M, Korbo L., et al. The new stereological tools: disec-tor, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS.1988;96(10):857-81.
  30. Hess R.A. Spermatogenesis overview, encyclopedia of reproduction.1999;(4):Academic press University f Illinois at Urbana.pp:534-45.
  31. Bar-Shira Maymon B., Yogev L., Marks A., Hauser R., Botchan A., Yavets H. Sertoli cell inactivation da-mage to the human testis after cancer chemotherapy. Fertil Stril.2004:81(5):1391-1394.
  32. Shinohara T., Orwig K.E., Avarbock M.R., Brinster R.L., Restoration of spermatogenesis in infertile mice by sertoli cell transplantation. Biol Reprod.2003;68(3): 1064-71.
  33. Choi Y.J., Ok D.W., Kwon D.N., Chung J.I., Kim H.C., et al. Murine male germ cell apoptosis induced by busulfan treatment correleates with loss of c-kit-expression in a Fas/FasL-and P53-independent manner. FEBS Lett.2004;575(1-3):41-51.
  34. Sawhney P., Gimmona C.J., Meistrich M.L., Richburg J.H. Cisplatin- induced long-term failure of spermato-genesis in adult C57/Bl/6J Mice. J Androl.2005;26(1): 136-45.
  35. Cai L., Hales B.F., Robaire B. Induction of apoptosis in the germ cells of adult male rats after exposure to cyclophosphamide. Biol Reprod.1997;56(6):1490-7.
  36. O Donell L., Robertson K.M., Jones M.E., Simpson E.R. Estrogen and spermatogenesis.2001;22(3):289-318.
  37. Siril Ariyaratne H.B., Ian Mason J., Mendis- Handagama S.M. Effects of thyroid and luteinizing hormones on the onset of precursor cell differentiation into leydig progenitor cells in the prepubertal rat testis. Biol Reprod.2000;63(3):898-904.
  38. Benton L., Shan L.X., Hardy M.P., Differentiation of adult Leydig cells. J Steroid Biochem Mol Biol.1995; 53(1-6):61-8.
  39. Mendis- Mandagama S.M.L., Risbridger G.P., de Kretser D.M. Morphometric analysis of the compo-nents of the neonatal and the adult rat testis intersti-tium. Int J Androl.1987;10:525-534.
  40. Qin D.N., Lung M.A. Morphometric study on leydig cells in capsulotomized testis of rats. Asian J Androl. 2002;4(1):49-53.
  41. Ballester J., Dominguez J., Munoz M.C., Sensat M., Rigau T., et al. Tungstate treatment improves Leydig cell function in streptozotocin- diabetic rats. J Androl. 2005;26(6):706-15.
  42. Howell S.J., Shalet S.M. Testicular function following chemotherapy. Hum Reprod Update.2001;7(4):363-9.
  43. Zhengwei Y., McLachlan R.I., Bremner W.J., Wre-ford N.G. Quantitative (stereological) study of the nor-mal spermatogenesis in the adult monkey (Macaca fa-scicularis). J Androl.1997;18(6):681-7.
  44. Meistrich M.L., Wilson G., Huhtaniemi I. Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis, Cancer Res.1999;59(15):3557-60.
  45. Tan K.A., Walker M., Morris K., Greig I., Mason J.I., Sharpe R.M. Infant feeding with soy formula milk: effects of puberty progression, reproductive function and testicular cell numbers in marmoset monkeys in adulthood. Hum Reprod.2006;21(4):896-904.
  46. Petersen P.M., Giwercman A., Gundersen H.J., Pak-kenberg B. Efficient and unbiased tools for quantitating laydig and sertoli cells in testes from testes biobsies. Image Anal Stereol.2000;19:113-117.

COPE
SID
NLM
AJMB
IJBMLE
IJBMLE

Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.